Cisplatin can be synergized with PD-1/PD-L1 blocking therapies to improve clinical efficacy; however, a preclinical trial by Liu et al. showed synergistic effects of PD-1 blockade on oxaliplatin-based chemotherapy for gastric cancer, but not on cisplatin-based chemotherapy [127]. The gene discussed is CD274; the disease is gastric cancer.